Lobbying

Bioflorida's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q2 2024; the issues it reports most are Budget/Appropriations and Copyright/Patent/Trademark.

Bioflorida

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

Bioflorida lobbying by quarter
Bioflorida lobbying by quarter
QuarterAmountReports
Q2 2024$01
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$20K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Budget and appropriations$22.9K · 8 reports
  • Copyright, patent and trademark$22.9K · 8 reports
  • Health issues$22.9K · 8 reports
  • Manufacturing$22.9K · 8 reports
  • Medical research and clinical labs$22.9K · 8 reports
  • Medicare and Medicaid$22.9K · 8 reports
  • Pharmacy$22.9K · 8 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Food & Drug Administration (FDA)8 reports
  • Health & Human Services, Dept of (HHS)8 reports
  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE8 reports

Firms it paid

Firm
Buchanan Ingersoll & Rooney PC$160K9 quarters

Former officials lobbying for it

Former position
AMANDA LINCOLNStaff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan CollinsQ4 2025

Lobbying reports

Filed by
07/20for Q2Buchanan Ingersoll & Rooney PC$20K
04/20for Q1Buchanan Ingersoll & Rooney PC$20K
01/20for Q4 2025Buchanan Ingersoll & Rooney PC$20K
25/10/20for Q3 2025Buchanan Ingersoll & Rooney PC$20K
25/07/22for Q2 2025Buchanan Ingersoll & Rooney PC$20K
25/04/21for Q1 2025Buchanan Ingersoll & Rooney PC$20K
25/03/06for Q4 2024Buchanan Ingersoll & Rooney PC$20K
25/03/06for Q3 2024Buchanan Ingersoll & Rooney PC$20K
25/01/21for Q4 2024Buchanan Ingersoll & Rooney PC$20K
24/10/21for Q3 2024Buchanan Ingersoll & Rooney PC$20K
24/07/22for Q2 2024Buchanan Ingersoll & Rooney PCUnder $5,000
24/07/01for Q2 2024Buchanan Ingersoll & Rooney PCUnder $5,000